Literature DB >> 17587827

Liver fibrosis: possible involvement of EMT.

Tadashi Ikegami1, Yining Zhang, Yasushi Matsuzaki.   

Abstract

Hepatic fibrosis is a wound-healing process in the liver with acute and chronic injury and is characterized by an excess production and deposition of extracellular matrix components. Hepatic stellate cells as well as portal fibroblasts play a pivotal role in the liver fibrogenesis. Regarding the origin of these mesenchymal cells, two hypotheses emerge. One hypothesis argues in favor of BM-derived progenitor cells and a second hypothesis favors epithelial-mesenchymal transition (EMT) in the local formation of these mesenchymal cells from hepatic epithelium. In this short review, we describe (1) the principle mechanisms of hepatic fibrosis, (2) the cells which play a crucial role in hepatic fibrosis, and (3) the possible involvement of EMT in the process of hepatic fibrosis and carcinogenesis. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17587827     DOI: 10.1159/000101322

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  14 in total

Review 1.  Recent advances in the pathogenesis and diagnosis of liver fibrosis.

Authors:  Natalie J Török
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

Review 2.  Notch in fibrosis and as a target of anti-fibrotic therapy.

Authors:  Biao Hu; Sem H Phan
Journal:  Pharmacol Res       Date:  2016-04-21       Impact factor: 7.658

3.  MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.

Authors:  Yoshinari Matsumoto; Saori Itami; Masahiko Kuroda; Katsutoshi Yoshizato; Norifumi Kawada; Yoshiki Murakami
Journal:  Mol Ther       Date:  2016-06-23       Impact factor: 11.454

Review 4.  Cardiac Fibrosis: The Fibroblast Awakens.

Authors:  Joshua G Travers; Fadia A Kamal; Jeffrey Robbins; Katherine E Yutzey; Burns C Blaxall
Journal:  Circ Res       Date:  2016-03-18       Impact factor: 17.367

5.  Hepatic stellate cells and parasite-induced liver fibrosis.

Authors:  Barrie Anthony; Jeremy T Allen; Yuesheng S Li; Donald P McManus
Journal:  Parasit Vectors       Date:  2010-07-21       Impact factor: 3.876

6.  Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.

Authors:  F van Zijl; M Mair; A Csiszar; D Schneller; G Zulehner; H Huber; R Eferl; H Beug; H Dolznig; W Mikulits
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

7.  Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation.

Authors:  Bin Li; Yun-Wen Zheng; Yuuki Sano; Hideki Taniguchi
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

8.  Suppression of CB1 cannabinoid receptor by lentivirus mediated small interfering RNA ameliorates hepatic fibrosis in rats.

Authors:  Si-Wen Chen; Ben-Yan Wu; Shi-Ping Xu; Ke-Xing Fan; Li Yan; Yuan Gong; Jun-Bao Wen; Dao-Hong Wu
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.

Authors:  Balarka Banerjee; Michael Musk; Erika N Sutanto; Stephanie T Yerkovich; Peter Hopkins; Darryl A Knight; Suzanna Lindsey-Temple; Stephen M Stick; Anthony Kicic; Daniel C Chambers
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis.

Authors:  Juan Zhao; Nan Tang; Kaiming Wu; Weiping Dai; Changhong Ye; Jian Shi; Junping Zhang; Beifang Ning; Xin Zeng; Yong Lin
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.